| Gene symbol | MUC16 | Synonyms | CA125 | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19p13.2 | dbXrefs | |
| Description | mucin 16, cell surface associated | ||||
| GTO ID | GTC2086 |
| Trial ID | NCT03907527 |
| Disease | Ovarian Carcinoma | Fallopian Tube Carcinoma | Peritoneal Carcinoma |
| Altered gene | MUC16 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | PRGN-3005 UltraCAR-T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Modified Immune Cells (Autologous CAR T Cells) in Treating Patients With Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer |
| Year | 2019 |
| Country | United States |
| Company sponsor | Precigen, Inc |
| Other ID(s) | RG1004303 |
| Cohort 1 | |||||||||
|
|||||||||